News & Filings
PIIND \u2014 Recent Activity
3 items in the last 14 days
AI Summary
As an Indian retail investor, you should be aware that PI Industries Ltd has been consistently reporting strong growth, particularly in the pharma sector, which may impact your investment portfolio. The company's earnings call highlights have shown resilience amidst challenges, with a focus on domestic growth. This information may be relevant to your financial decisions, especially if you have investments in PI Industries Ltd or are considering the pharmaceutical industry as a whole.
PI Industries Ltd (BOM:523642) Q3 2026 Earnings Call Highlights: Strong Pharma Growth and ...
PI Industries Ltd (BOM:523642) reports robust Pharma growth and innovation in AgChem, while navigating global market headwinds and liquidity challenges.
Click to open →
PI Industries Ltd (BOM:523642) Q2 2026 Earnings Call Highlights: Navigating Growth Amidst Challenges
Despite a decline in revenue, PI Industries Ltd (BOM:523642) showcases robust growth in its pharma and chemical exports segments, while investing strategically in biologicals for future expansion.
Click to open →
PI Industries Ltd (BOM:523642) Q4 2025 Earnings Call Highlights: Strong Domestic Growth Amid ...
PI Industries Ltd (BOM:523642) reports robust domestic branded revenue growth and strategic advancements despite global market pressures and increased tax rates.
Click to open →
Get alerts for important filings
Add PIIND to your watchlist for board meeting & dividend alerts.
Open analysis →News from yfinance + BSE corporate announcements. Importance scoring is automated. YieldIQ is not registered with SEBI as an investment adviser.